Hostname: page-component-78c5997874-lj6df Total loading time: 0 Render date: 2024-11-18T08:55:39.528Z Has data issue: false hasContentIssue false
  • English
  • Français

The Pharmacological Management of Epilepsy Associated with Psychological Disorders

Published online by Cambridge University Press:  29 January 2018

E. H. Reynolds
E. H. Reynolds*
Affiliation:
Denmark Hill, London SE5
Get access Rights & Permissions [Opens in a new window]

Summary

The anticonvulsant treatment of epilepsy associated with psychological disorders is reviewed in the light of modern knowledge of the clinical pharmacology and adverse mental effects of the drugs. Careful monitoring of individual drug therapy from the onset of treatment improves compliance and seizure control and avoids unnecessary and harmful polypharmacy, and some of the neurological and psychosocial problems of chronic epilepsy. In chronic patients on polypharmacy cautious rationalization may improve mental function but can be hazardous due to withdrawal seizures. A clearer perception of the limits of anticonvulsant therapy will allow more attention to appropriate psychosocial measures.

Type
Practical Guides
Information
The British Journal of Psychiatry , Volume 141 , Issue 6 , December 1982 , pp. 549 - 557
Copyright
Copyright © Royal College of Psychiatrists, 1982 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Coatsworth, J. J. (1971) Studies on the Clinical Efficacy of Marketed Anticonvulsant Drugs. NINDS Monograph No. 12. Washington DC: US Government Printing Office.Google Scholar
Corbett, J., Driver, M. & Reynolds, E. H. (1980) Valproate encephalopathy. Communication to British Branch of the International League Against Epilepsy.Google Scholar
Dellaportas, C. I., Shorvon, S. D., Galbraith, A. W., Laundy, M., Reynolds, E. H. Marshall, W. J. & Chanarin, I. (1982) Chronic toxicity in epileptic patients on single drug treatment. British Medical Journal, 285, 409–40.Google Scholar
Eadie, M. J. & Tyrer, J. H. (1980) Anticonvulsant Therapy. Pharmacological basis and practice. Edinburgh: Churchill Livingstone.Google Scholar
Gowers, W. R. (1881) Epilepsy and Other Chronic Convulsive Diseases. London: Churchill.Google Scholar
Graham, P. & Rutter, M. (1968) Organic brain dysfunction and child psychiatric disorder. British Medical Journal, iii, 695–700.Google Scholar
Guelen, P. J. M., Van der Kleijn, E. & Woudstra, V. (1975) Statistical analysis of pharmacokinetic parameters in epileptic patients chronically treated with antiepileptic drugs. In Clinical Pharmacology of Antiepileptic Drugs, (eds. Schneider, H., Janz, D., Gardner-Thorpe, C., Meinardi, H. and Sherwin, A. L.), pp. 2–10. Berlin: Springer-Verlag.Google Scholar
Hauser, W. A. & Kurland, L. T. (1975) The epidemiology of epilepsy in Rochester, Minnesota, 1935 through 1967. Epilepsia, 16, 1–66.CrossRefGoogle ScholarPubMed
Juul-Jensen, P. & Ipsen, J. (1975) Prevalens og incidens af epilepsi i Stor Arhus. Ugeskrift for Laeger, 137, 2380–8.Google Scholar
Landolt, H. (1958) Serial electroencephalographic investigations during psychotic episodes in epileptic patients and during schizophrenic attacks. In Lectures on Epilepsy, (ed. Lorentz de Haas, A. M.), pp. 91–133. Amsterdam: Elsevier.Google Scholar
MacCallum, W. A. G. (1980) Interaction of lithium and phenytoin. British Medical Journal, 280, 610–11.CrossRefGoogle ScholarPubMed
Milano Collaborative Group for Studies on Epilepsy (1977) Long-term monitoring in the difficult patient. Preliminary results of 16 months of observations— usefulness and limitations. In Antiepileptic Drug Monitoring, (eds. Gardner-Thorpe, C., Janz, D., Meinardi, H. and Pippinger, C. E.), pp. 197–213. Tunbridge Wells: Pitman.Google Scholar
Ounsted, C. (1955) The hyperkinetic syndrome in epileptic children. Lancet, 2, 303–11.Google Scholar
Parnas, J., Flachs, H. & Gram, L. (1979) Psychotropic effect of antiepileptic drugs. Acta Neurologica Scandinavica, 80, 329–43.Google Scholar
Perucca, E. (1982) Drug interactions. In A Textbook of Epilepsy, (eds. Laidlaw, J. and Richens, A.), pp. 358–71. Edinburgh: Churchill Livingstone.Google Scholar
Pond, D. A. (1961) Psychiatric aspects of epileptic and brain-damaged children. British Medical Journal, 2, 1377–82.Google Scholar
Pond, D. A. (1981) Psychosocial aspects of epilepsy—the family. In Epilepsy and Psychiatry, (eds. Reynolds, E. H. and Trimble, M. R.), pp. 291–5. Edinburgh: Churchill Livingstone.Google Scholar
Pond, D. A. & Bidwell, B. H. (1960) A survey of epilepsy in 14 general practices 2. Social and psychological aspects. Epilepsia, 1, 285–99.Google Scholar
Reynolds, E. H. (1970) Iatrogenic disorders in epilepsy. In Modern Trends in Neurology, No. 5, (ed. Williams, D.), pp 271–86. London: Butterworths.Google Scholar
Reynolds, E. H. (1975) Chronic antiepileptic toxicity: a review. Epilepsia, 16, 319–52.Google Scholar
Reynolds, E. H. (1978) Drug treatment of epilepsy. Lancet, 2, 721–5.Google Scholar
Reynolds, E. H. (1980a) Serum levels of anticonvulsant drugs, interpretation and clinical value. Pharmacology and Therapeutics, 8, 217–35.Google Scholar
Reynolds, E. H. (1980b) Chronic toxicity of antiepileptic drugs. Irish Medical Journal, (Supplement), 73, 45–51.Google Scholar
Reynolds, E. H. (1981) Biological factors in psychological disorders associated with epilepsy. In Epilepsy and Psychiatry, (eds. Reynolds, E. H. and Trimble, M. R.), pp. 264–90. Edinburgh: Churchill Livingstone.Google Scholar
Reynolds, E. H. & Shorvon, S. D. (1981) Monotherapy or poly-therapy for epilepsy? Epilepsia, 22, 1–20.Google Scholar
Richens, A. (1976) Drug Treatment of Epilepsy. London: Henry Kimpton.Google Scholar
Rodin, E. A. (1968) The Prognosis of Patients with Epilepsy. Springfield: Thomas.Google Scholar
Shorvon, S. D. & Reynolds, E. H. (1979) Reduction of polypharmacy for epilepsy. British Medical Journal, 2, 1023–5.Google Scholar
Shorvon, S. D. & Reynolds, E. H. (1982a) The early prognosis of epilepsy. British Medical Journal. In press.Google Scholar
Shorvon, S. D. & Reynolds, E. H. (1982b) Anticonvulsant peripheral neuropathy: a clinical and electrophysiological study of patients on single drug treatment with phenytoin, carbamazepine or barbiturates. Journal of Neurology, Neurosurgery and Psychiatry, 45, 620–6.Google Scholar
Shorvon, S. D., Johnson, A. L. & Reynolds, E. H. (1981) Statistical and theoretical considerations in the design of anticonvulsant trials. In Advances in Epileptology, (eds. Dam, M., Gram, L. and Penry, J. K.), pp. 123–8. New York: Raven Press.Google Scholar
Speirs, J. & Hirsch, S. R. (1978) Severe lithium toxicity with normal serum concentrations. British Medical Journal, i, 815–16.Google Scholar
Thompson, P. J. (1981) The effects of anticonvulsant drugs on the cognitive functioning of normal volunteers and patients with epilepsy. Ph.D. thesis. London University.Google Scholar
Thompson, P. J. & Trimble, M. R. (1981) Sodium valproate and cognitive functioning in normal volunteers. British Journal of Clinical Pharmacology, 12, 819–24.Google Scholar
Trimble, M. (1979) The effect of anti-convulsant drugs on cognitive abilities. Pharmacology and Therapeutics, 4, 677–85.CrossRefGoogle ScholarPubMed
Trimble, M. (1981) Psychotropic drugs in the management of epilepsy. In Epilepsy and Psychiatry, (eds. Reynolds, E. H. and Trimble, M. R.), pp. 337–46. Edinburgh: Churchill Livingstone.Google Scholar
Trimble, M. & Reynolds, E. H. (1976) Anticonvulsant drugs and mental symptoms: A review. Psychological Medicine, 6, 169–78.Google Scholar
Woodbury, D. M., Penry, J. K. & Schmidt, R. P. (eds.) (1972) Antiepileptic Drugs. New York: Raven Press.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.